Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.8M Buy
305,415
+12,044
+4% +$2.18M 0.62% 37
2026
Q1
$43.2M Buy
293,371
+2,609
+0.9% +$424K 0.68% 34
2025
Q4
$56.7M Buy
290,762
+1,241
+0.4% +$295K 0.87% 25
2025
Q3
$81.4M Sell
289,521
-6,327
-2% -$1.61M 1.29% 21
2025
Q2
$64.7M Buy
295,848
+9,469
+3% +$1.53M 1.12% 22
2025
Q1
$40M Buy
286,379
+1,600
+0.6% +$260K 0.78% 26
2024
Q4
$47.5M Buy
284,779
+1,705
+0.6% +$303K 0.89% 25
2024
Q3
$48.2M Buy
283,074
+144
+0.1% +$20.9K 0.93% 23
2024
Q2
$39.9M Buy
282,930
+1,943
+0.7% +$241K 0.8% 28
2024
Q1
$35.3M Buy
280,987
+7,347
+3% +$841K 0.76% 30
2023
Q4
$28.8M Buy
273,640
+4,059
+2% +$443K 0.71% 40
2023
Q3
$28.6M Buy
269,581
+8,049
+3% +$932K 0.79% 33
2023
Q2
$31.1M Buy
261,532
+4,277
+2% +$442K 0.85% 31
2023
Q1
$23.9M Buy
257,255
+7,368
+3% +$646K 0.72% 38
2022
Q4
$20.4M Buy
249,887
+3,511
+1% +$267K 0.68% 45
2022
Q3
$15M Buy
246,376
+5,806
+2% +$425K 0.57% 52
2022
Q2
$16.8M Buy
240,570
+2,985
+1% +$219K 0.62% 49
2022
Q1
$19.7M Buy
237,585
+9,714
+4% +$787K 0.64% 47
2021
Q4
$19.9M Buy
227,871
+5,807
+3% +$545K 0.66% 49
2021
Q3
$19.3M Buy
222,064
+4,835
+2% +$427K 0.75% 43
2021
Q2
$16.9M Buy
217,229
+11,147
+5% +$873K 0.65% 54
2021
Q1
$14.5M Buy
206,082
+12,703
+7% +$822K 0.62% 53
2020
Q4
$12.5M Buy
193,379
+2,208
+1% +$131K 0.58% 57
2020
Q3
$11.4M Buy
191,171
+9,767
+5% +$555K 0.59% 53
2020
Q2
$10M Buy
181,404
+24,833
+16% +$1.32M 0.57% 53
2020
Q1
$7.57M Buy
156,571
+23,949
+18% +$1.24M 0.52% 58
2019
Q4
$7.03M Buy
132,622
+2,732
+2% +$150K 0.39% 76
2019
Q3
$7.15M Buy
129,890
+21,138
+19% +$1.17M 0.43% 66
2019
Q2
$6.2M Buy
108,752
+1,928
+2% +$104K 0.38% 82
2019
Q1
$5.74M Sell
106,824
-1,033
-1% -$52.6K 0.37% 81
2018
Q4
$4.87M Buy
107,857
+16,959
+19% +$813K 0.36% 82
2018
Q3
$4.69M Buy
90,898
+3,431
+4% +$167K 0.3% 94
2018
Q2
$3.85M Buy
87,467
+13,812
+19% +$636K 0.29% 92
2018
Q1
$3.37M Buy
73,655
+36,383
+98% +$1.81M 0.23% 106
2017
Q4
$1.76M Buy
37,272
+200
+0.5% +$9.81K 0.12% 134
2017
Q3
$1.79M Sell
37,072
-976
-3% -$48.6K 0.13% 130
2017
Q2
$1.91M Sell
38,048
-1,603
-4% -$73.1K 0.15% 115
2017
Q1
$1.77M Hold
39,651
0.14% 118
2016
Q4
$1.52M Buy
+39,651
New +$1.55M 0.13% 124
2015
Q4
$1.3M Buy
+35,605
New +$1.36M 0.14% 122
2014
Q4
$1.55M Buy
+34,426
New +$1.4M 0.17% 92
2013
Q4
$1.61M Buy
+41,995
New +$1.44M 0.18% 82

Other funds holding ORCL

Glenview Trust's ORCL Position: Q2 2026 in Review

Glenview Trust increased its Oracle (ORCL) stake by 4.1% in Q2 2026, buying an estimated $2.18M and bringing the position to 305,415 shares worth $44.8M. The position accounts for 0.62% of the portfolio, ranked #37.

Glenview Trust first reported a position in ORCL in Q4 2013 and has held it in 42 quarters since. The position peaked at $81.4M in Q3 2025. 3,503 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Glenview Trust held 305,415 shares of Oracle worth $44.8M as of Q2 2026.
  • Glenview Trust bought 12,044 Oracle shares in Q2 2026, an estimated $2.18M.
  • Oracle made up 0.62% of Glenview Trust's portfolio in Q2 2026, its #37 holding.
  • Glenview Trust first reported a position in Oracle in Q4 2013 and has held it in 42 quarters since.
  • Glenview Trust's Oracle position peaked at $81.4M in Q3 2025.
  • 3,503 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.